With India aiming to achieve Universal Health Coverage for its masses and the inception of path-breaking schemes like Ayushman Bharat launched towards this goal, the healthcare scenario in the country is expected to improve. However, there are other areas where the law and policy have contributed towards better access to healthcare. One such contributor is the patent law of India that deserves to be lauded for its role in making important medicines accessible. This paper seeks to deliberate upon the law relating to secondary patents in India and its effective role in mitigation of drug prices.

Research Methodology: This paper analyses the retail drug prices of three best selling drugs in the India in the light of the law and policy practiced in India also drawing a comparison to their respective prices in the USA.